中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
23期
1-1,3
,共2页
乳腺导管原位癌%超声%钼靶X线
乳腺導管原位癌%超聲%鉬靶X線
유선도관원위암%초성%목파X선
Breast ductal carcinoma in situ%Ultrasound%Line of molybdenum target X
目的探讨超声联合数字钼靶X线对不同级别乳腺导管原位癌(DCIS)的应用价值。方法经病理学证实的48例女性乳腺导管原位癌,均采用彩色多普勒超声检查和钼靶X线检查对不同级别导管原位癌进行诊断与鉴别诊断。结果钼靶对低、中、高级别导管原位癌诊断为BI-RADS4或5级(中度或高度怀疑恶性病变)分别为7例、8例、20例;彩色多普勒超声对低、中、高级别导管原位癌诊断为BI-RADS4或5级分别为8例、9例、17例;同时两种方法联合对低、中、高级别导管原位癌诊断为BI-RADS4或5级分别为9例、10例、21例。结论彩色多普勒超声与钼靶X线摄影联合应用可提高对不同级别导管原位癌诊断率,值得临床推广。
目的探討超聲聯閤數字鉬靶X線對不同級彆乳腺導管原位癌(DCIS)的應用價值。方法經病理學證實的48例女性乳腺導管原位癌,均採用綵色多普勒超聲檢查和鉬靶X線檢查對不同級彆導管原位癌進行診斷與鑒彆診斷。結果鉬靶對低、中、高級彆導管原位癌診斷為BI-RADS4或5級(中度或高度懷疑噁性病變)分彆為7例、8例、20例;綵色多普勒超聲對低、中、高級彆導管原位癌診斷為BI-RADS4或5級分彆為8例、9例、17例;同時兩種方法聯閤對低、中、高級彆導管原位癌診斷為BI-RADS4或5級分彆為9例、10例、21例。結論綵色多普勒超聲與鉬靶X線攝影聯閤應用可提高對不同級彆導管原位癌診斷率,值得臨床推廣。
목적탐토초성연합수자목파X선대불동급별유선도관원위암(DCIS)적응용개치。방법경병이학증실적48례녀성유선도관원위암,균채용채색다보륵초성검사화목파X선검사대불동급별도관원위암진행진단여감별진단。결과목파대저、중、고급별도관원위암진단위BI-RADS4혹5급(중도혹고도부의악성병변)분별위7례、8례、20례;채색다보륵초성대저、중、고급별도관원위암진단위BI-RADS4혹5급분별위8례、9례、17례;동시량충방법연합대저、중、고급별도관원위암진단위BI-RADS4혹5급분별위9례、10례、21례。결론채색다보륵초성여목파X선섭영연합응용가제고대불동급별도관원위암진단솔,치득림상추엄。
Objective To investigate the ultrasound combined with digital mammography X-ray of different grade Ductal carcinoma in situ (Ductal carcinoma in situ, DCIS) application value. Method Conifrmed by pathology of 48 cases of female breast ductal carcinoma in situ, all use of color doppler ultrasound and molybdenum target X-ray on different levels for diagnosis and differential diagnosis of ductal carcinoma in situ. Results Mammography for low, medium and high grade ductal carcinoma in situ diagnosis of BI-RADS4 or level 5 (moderately or highly suspected malignant lesions) of 7 cases respectively, 8 cases, 20 cases;color doppler lfow imaging (cdif) in low, medium and high grade ductal carcinoma in situ diagnosis of BI-RADS4 or level 5 of 8 cases, 9 cases, 17 cases respectively;the combination of the two methods at the same time low, medium and high grade ductal carcinoma in situ diagnosis of BI-RADS4 or level 5 of 9 cases, 10 cases, 21 cases respectively. Conclusion Color doppler ultrasonography and molybdenum target X-ray photography combined use of ductal carcinoma in situ with different grades can be improved diagnostic rate, worthy of clinical promotion.